These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 25559951)

  • 21. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer stem cells: current advances and clinical implications.
    Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
    Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nerve growth factor and proNGF simultaneously promote symmetric self-renewal, quiescence, and epithelial to mesenchymal transition to enlarge the breast cancer stem cell compartment.
    Tomellini E; Touil Y; Lagadec C; Julien S; Ostyn P; Ziental-Gelus N; Meignan S; Lengrand J; Adriaenssens E; Polakowska R; Le Bourhis X
    Stem Cells; 2015 Feb; 33(2):342-53. PubMed ID: 25286822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic regulators governing cancer stem cells and epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Patel S; Shah K; Mirza S; Daga A; Rawal R
    Curr Stem Cell Res Ther; 2015; 10(2):140-52. PubMed ID: 25330402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
    Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
    Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1.
    Gao Y; Zhao Y; Zhang J; Lu Y; Liu X; Geng P; Huang B; Zhang Y; Lu J
    Sci Rep; 2016 Jan; 6():19874. PubMed ID: 26813495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen-resistant breast cancer cells possess cancer stem-like cell properties.
    Liu H; Zhang HW; Sun XF; Guo XH; He YN; Cui SD; Fan QX
    Chin Med J (Engl); 2013 Aug; 126(16):3030-4. PubMed ID: 23981606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
    Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
    Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
    Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
    Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.
    West NR; Murray JI; Watson PH
    Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.
    May CD; Sphyris N; Evans KW; Werden SJ; Guo W; Mani SA
    Breast Cancer Res; 2011 Feb; 13(1):202. PubMed ID: 21392411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells.
    Wang X; Liu J; Wang Z; Huang Y; Liu W; Zhu X; Cai Y; Fang X; Lin S; Yuan L; Ouyang G
    PLoS One; 2013; 8(8):e72962. PubMed ID: 24009721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
    Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
    Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast-cancer stem cells-beyond semantics.
    Badve S; Nakshatri H
    Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth.
    Weidenfeld K; Schif-Zuck S; Abu-Tayeh H; Kang K; Kessler O; Weissmann M; Neufeld G; Barkan D
    Oncotarget; 2016 Nov; 7(44):71362-71377. PubMed ID: 27655685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.